ROLLINS JOHN WOODSON reported 2 transactions at 20/20 BIOLABS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/23/2026ACC: 0001213900-26-019456
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
19.16K acquired · 19.16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.03K
Price / share
—
Trade value
—
% of position
117.3%
2/19/2026
11.11K→24.14K
Common Stock
Direct
Shares
+6.13K
Price / share
—
Trade value
—
% of position
25.4%
2/19/2026
24.14K→30.27K
Total
Net shares
+19.16K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/19/2026 | C · Conversion | +13.03K | — | — | 117.3% | 11.11K | 24.14K |
| Common Stock Direct | 2/19/2026 | C · Conversion | +6.13K | — | — | 25.4% | 24.14K | 30.27K |
| Total | +19.16K | $0.00 | ||||||
Derivative Transactions2
Series A Preferred Stock
Direct
Converts to
Common Stock
13.03K shares
Shares
−13.03K
Strike price
Held after
0.00
Exercisable
—
2/19/2026
Series A-2 Preferred Stock
Direct
Converts to
Common Stock
6.13K shares
Shares
−6.13K
Strike price
Held after
0.00
Exercisable
—
2/19/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock13.03K shares | 2/19/2026 | C · Conversion | −13.03K | — | 0.00 | |
| Series A-2 Preferred Stock Direct | Common Stock6.13K shares | 2/19/2026 | C · Conversion | −6.13K | — | 0.00 |